Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-23.42	60.87	79.49
Graham Fair Price	39.38	60.80	43.62
PEG	-7.17	0.36	0.39
Price/Book	-1.97	2.73	2.78
Price/Cash Flow	88.86	183.63	97.23
Prices/Earnings	-48.07	32.57	62.72
Price/Sales	-7.42	13.87	14.98
Price/FCF	88.86	183.63	97.23
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	6.03	0.46	0.43
Operating Margin	51.83	0.17	0.11
ROA	84.46	< 0.005	< 0.005
ROE	0.01	0.02	88.76
ROIC	< 0.005	0.02	66.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.12	-0.02	545.47
Dividends QOQ	0.04	< 0.005	-94.79
EBIT QOQ	0.06	0.63	1029.82
EPS QOQ	1.62	0.91	-44.05
FCF QOQ	-0.30	-0.47	-60.24
Revenue QOQ	-0.07	0.07	-3.82
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	111.00	106.02	-4.48
Days Sales Outstanding (DSO)	43.36	45.65	5.30
Inventory Turnover	0.81	0.85	4.69
Debt/Capitalization	0.39	0.41	6.13
Quick Ratio	0.46	0.79	69.80
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	87.32	88.59	1.45
Cash	4.26	11.13	161.13
Capex	-0.40	-0.46	-15.75
Free Cash Flow	2.50	1.32	-47.34
Revenue	16.22	17.43	7.42
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.08	1.41	30.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	13.85	11.11	-19.81
Naive Interpretation	Member

06 - Financial Health · Weak

Rating